General Information of the Cell Line
Cell Line ID
CL000805
Cell Line Name
HBE1
Synonyms
HBE-1
Human Bronchial Epithelial cell Line 1
Category
Transformed cell line
Organism
Homo sapiens (Human)
Tissue Information
Lung
Disease None
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02042, ATP-binding cassette sub-family C member 7
Compound ID Compound Name Compound Formula
CP0579435
2-[6-(difluoromethyl)pyridin-2-yl]-1-(2-methoxy-5-methylphenyl)-N-(2-methylquinolin-5-yl)sulfonylcyclopropane-1-carboxamide
   Show/Hide
C28H25F2N3O4S
 1
1
EC50 = 0.4 nM
   TI
   LI
   LO
   TS
CP0571389
1-(2-methoxy-5-methylphenyl)-N-(2-methylquinolin-5-yl)sulfonyl-2-[3-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide
   Show/Hide
C29H25F3N2O4S
 1
1
EC50 = 0.51 nM
   TI
   LI
   LO
   TS
CP0575716
1-(2-methoxy-5-methylphenyl)-2-(4-methoxyphenyl)-N-(2-methylquinolin-5-yl)sulfonylcyclopropane-1-carboxamide
   Show/Hide
C29H28N2O5S
 1
1
EC50 = 0.66 nM
   TI
   LI
   LO
   TS
CP0571732
1-(2-methoxy-5-methylphenyl)-2-(4-methylphenyl)-N-(2-methylquinolin-5-yl)sulfonylcyclopropane-1-carboxamide
   Show/Hide
C29H28N2O4S
 1
1
EC50 = 0.8 nM
   TI
   LI
   LO
   TS
CP0571138
1-(2-methoxy-5-methylphenyl)-2-(3-methoxyphenyl)-N-(2-methylquinolin-5-yl)sulfonylcyclopropane-1-carboxamide
   Show/Hide
C29H28N2O5S
 1
1
EC50 = 0.84 nM
   TI
   LI
   LO
   TS
CP0578716
1-(2-methoxy-5-methylphenyl)-N-(2-methylquinolin-5-yl)sulfonyl-2-(6-propan-2-yloxypyridin-2-yl)cyclopropane-1-carboxamide
   Show/Hide
C30H31N3O5S
 1
1
EC50 = 0.9 nM
   TI
   LI
   LO
   TS
CP0388845
N-(4-tert-butyl-3-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
   Show/Hide
C20H20N2O3
 1
1
EC50 = 5 nM
   TI
   LI
   LO
   TS
CP0362762
3-amino-N-[(2S)-2-hydroxypropyl]-5-[4-(trifluoromethoxy)phenyl]sulfonylpyridine-2-carboxamide
   Show/Hide
C16H16F3N3O5S
 1
1
EC50 = 18 nM
   TI
   LI
   LO
   TS
CP0088272
CHEBI:66901
   Show/Hide
C24H28N2O3
 4
1
EC50 = 22 nM
   TI
   LI
   LO
   TS
2
EC50 = 34 nM
   TI
   LI
   LO
   TS
3
EC50 = 68 nM
   TI
   LI
   LO
   TS
4
EC50 = 236 nM
   TI
   LI
   LO
   TS
CP0490597
N-[4-tert-butyl-5-hydroxy-2-(trifluoromethyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide
   Show/Hide
C21H19F3N2O3
 1
1
EC50 = 22 nM
   TI
   LI
   LO
   TS
CP0494908
(2S,3S,4S,5S)-3-tert-butyl-4-(2-methylanilino)-1-[(2S)-oxane-2-carbonyl]-5-(2-propan-2-ylphenyl)pyrrolidine-2-carboxylic acid
   Show/Hide
C31H42N2O4
 1
1
EC50 = 22 nM
   TI
   LI
   LO
   TS
CP0532736
3-Amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methyl-propyl)-amide
   Show/Hide
C11H10BrF6N3O2
 1
1
EC50 = 25 nM
   TI
   LI
   LO
   TS
CP0551217
US10117858, Example 5
   Show/Hide
C12H13F6N3O3
 2
1
EC50 = 39 nM
   TI
   LI
   LO
   TS
2
EC50 = 72 nM
   TI
   LI
   LO
   TS
CP0527765
(2S,3S,4S,5S)-3-tert-butyl-5-[(5-cyclobutyl-2-methoxypyridin-3-yl)methyl]-4-[(5-cyclobutyl-2-methoxypyridin-3-yl)methylamino]-1-[(2S)-oxane-2-carbonyl]pyrrolidine-2-carboxylic acid
   Show/Hide
C37H52N4O6
 1
1
EC50 = 41 nM
   TI
   LI
   LO
   TS
CP0387052
N-(3-tert-butyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
   Show/Hide
C22H21N3O2
 1
1
EC50 = 42 nM
   TI
   LI
   LO
   TS
CP0400231
N-(4-tert-butyl-2-fluoro-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
   Show/Hide
C20H19FN2O3
 1
1
EC50 = 45 nM
   TI
   LI
   LO
   TS
CP0494401
N-(5-tert-butyl-1H-indol-6-yl)-4-oxo-1H-quinoline-3-carboxamide
   Show/Hide
C22H21N3O2
 1
1
EC50 = 97 nM
   TI
   LI
   LO
   TS
CP0532463
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-tert-butyl-2-methoxypyridin-3-yl)methylamino]-1-(cyclohexanecarbonyl)-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C33H47N3O4
 1
1
EC50 = 107 nM
   TI
   LI
   LO
   TS
CP0562768
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-tert-butyl-2-methoxyphenyl)methylamino]-1-(cyclohexanecarbonyl)-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C34H48N2O4
 1
1
EC50 = 113 nM
   TI
   LI
   LO
   TS
CP0527833
(2S,3S,4S,5S)-4-[[5-(1-adamantyl)-2-methoxyphenyl]methylamino]-3-tert-butyl-1-(cyclohexanecarbonyl)-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C40H54N2O4
 1
1
EC50 = 136 nM
   TI
   LI
   LO
   TS
CP0353054
(2S,3S,4S,5S)-3-tert-butyl-4-[[2-(dimethylamino)pyridin-3-yl]amino]-1-[(2S)-oxane-2-carbonyl]-5-(2-propan-2-ylphenyl)pyrrolidine-2-carboxylic acid
   Show/Hide
C31H44N4O4
 1
1
EC50 = 142 nM
   TI
   LI
   LO
   TS
CP0569896
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-tert-butyl-2-methoxyphenyl)methylamino]-5-[[2-methoxy-5-(trifluoromethyl)pyridin-3-yl]methyl]-1-[(2S)-oxane-2-carbonyl]pyrrolidine-2-carboxylic acid
   Show/Hide
C35H48F3N3O6
 1
1
EC50 = 159 nM
   TI
   LI
   LO
   TS
CP0576906
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-cyclobutyl-2-methoxypyridin-3-yl)methylamino]-1-(cyclohexanecarbonyl)-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C33H45N3O4
 1
1
EC50 = 184 nM
   TI
   LI
   LO
   TS
CP0532464
(2S,3S,4S,5S)-3-tert-butyl-1-(cyclohexanecarbonyl)-4-[(2-methoxy-5-propan-2-ylphenyl)methylamino]-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C33H46N2O4
 1
1
EC50 = 188 nM
   TI
   LI
   LO
   TS
CP0575054
(2S,3S,4S,5S)-3-tert-butyl-1-(cyclohexanecarbonyl)-4-[[2-methoxy-5-(3-tricyclo[3.1.0.01,3]hexanyl)phenyl]methylamino]-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C36H46N2O4
 1
1
EC50 = 190 nM
   TI
   LI
   LO
   TS
CP0527764
(2S,3S,4S,5S)-3-tert-butyl-1-(cyclohexanecarbonyl)-4-[[2-methoxy-5-(trifluoromethyl)pyridin-3-yl]methylamino]-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C30H38F3N3O4
 1
1
EC50 = 210 nM
   TI
   LI
   LO
   TS
CP0543195
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-chloro-2-methoxyphenyl)methylamino]-1-(cyclohexanecarbonyl)-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C30H39ClN2O4
 1
1
EC50 = 241 nM
   TI
   LI
   LO
   TS
CP0575055
(2S,3S,4S,5S)-3-tert-butyl-4-[(5-tert-butyl-2-methoxyphenyl)methylamino]-1-[(2S)-oxane-2-carbonyl]-5-phenylpyrrolidine-2-carboxylic acid
   Show/Hide
C33H46N2O5
 1
1
EC50 = 321 nM
   TI
   LI
   LO
   TS
CP0550164
(6R,12R)-17-amino-12-(hydroxymethyl)-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C17H18F6N4O4
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0550165
(6R,12R)-17-amino-8,9-dideuterio-12-methyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C17H18F6N4O3
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0550166
(6R)-17-amino-11,11-dimethyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C18H20F6N4O3
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0577539
(6R,12S)-17-amino-12-methyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C17H18F6N4O3
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0579031
17-amino-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C16H16F6N4O3
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0579780
(6R)-17-amino-6,15-bis(trifluoromethyl)-19-oxa-13-thia-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(17),2,4,14(18),15-pentaen-6-ol
   Show/Hide
C16H16F6N4O2S
 1
1
EC50 < 500 nM
   TI
   LI
   LO
   TS
CP0385469
7,9-Dimethyl-6-(5-methyl-furan-2-yl)-11-phenyl-6,7-dihydro-5H-5,7,9,11a-tetraaza-benzo[a]fluorene-8,10-dione
   Show/Hide
C26H22N4O3
 1
1
IC50 < 1000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Lung)
Cell Line Name Organism Disease
T84 Homo sapiens (Human) Colon adenocarcinoma
CFBE41o- Homo sapiens (Human) Cystic fibrosis
A-549 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1975 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2073 Homo sapiens (Human) Lung adenocarcinoma
HCC827 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2228 Homo sapiens (Human) Lung adenocarcinoma
A-427 Homo sapiens (Human) Lung adenocarcinoma
HCC44 Homo sapiens (Human) Lung adenocarcinoma
HCC1171 Homo sapiens (Human) Lung adenocarcinoma
MR-5 Homo sapiens (Human) Lung adenocarcinoma
NCI-H522 Homo sapiens (Human) Lung adenocarcinoma
HCC366 Homo sapiens (Human) Lung adenosquamous carcinoma
NCI-H1581 Homo sapiens (Human) Lung large cell carcinoma
DMS 53 Homo sapiens (Human) Lung small cell carcinoma
NCI-H1417 Homo sapiens (Human) Lung small cell carcinoma
SW900 Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H520 Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1703 Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H2286 Homo sapiens (Human) Lung squamous cell carcinoma
Malme-3M Homo sapiens (Human) Melanoma
NCI-H358 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
LLTC Mus musculus (Mouse) Malignant tumors of the mouse pulmonary system
LLTC Mus musculus (Mouse) Malignant tumors of the mouse pulmonary system
T8 Rattus norvegicus (Rat) Rat malignant mesothelioma
V79MZ Cricetulus griseus (Chinese hamster) -
V79 Cricetulus griseus (Chinese hamster) -
V79MZh11B2 Cricetulus griseus (Chinese hamster) -
V79MZh11B1 Cricetulus griseus (Chinese hamster) -
Dede Cricetulus griseus (Chinese hamster) -
39ER22 Cricetulus griseus (Chinese hamster) -
PS120 Cricetulus griseus (Chinese hamster) -
CHL Cricetulus griseus (Chinese hamster) -
NP1 Homo sapiens (Human) -
IMR-90 Homo sapiens (Human) -
Hs 888.Lu Homo sapiens (Human) -
BEAS-2B Homo sapiens (Human) -
WI-38 Homo sapiens (Human) -
HL Homo sapiens (Human) -
HFL1 Homo sapiens (Human) -
WI-38 VA13 subline 2RA Homo sapiens (Human) -
16HBE14o- Homo sapiens (Human) -
NAL1A clone C4E10 Mus musculus (Mouse) -
Mv1Lu Neovison vison (American mink) -
RFL-6 Rattus norvegicus (Rat) -
PAC1 Rattus norvegicus (Rat) -
RLE Rattus norvegicus (Rat) -